Proposed Data Collection; Comment Request; California Health Interview Survey 2007, 51833-51834 [06-7328]

Download as PDF Federal Register / Vol. 71, No. 169 / Thursday, August 31, 2006 / Notices electronically each every fiscal year at https://www.grants.gov. Joan E. Ohl, Commissioner, Administration on Children, Youth and Families. [FR Doc. 06–7364 Filed 8–30–06; 8:45 am] BILLING CODE 4184–01–P Dated: August 25, 2006. Randall W. Lutter, Associate Commissioner for Policy and Planning. [FR Doc. 06–7310 Filed 8–30–06; 8:45 am] DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration Anti-Infective Drugs Advisory Committee Meeting; Amendment of Notice AGENCY: BILLING CODE 4160–01–S Food and Drug Administration, HHS. ACTION: Notice. erjones on PROD1PC72 with NOTICES 15:29 Aug 30, 2006 DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health The Food and Drug Administration (FDA) is announcing an amendment to the notice of a meeting of the Anti-Infective Drugs Advisory Committee. This meeting was announced in the Federal Register of July 25, 2006 (71 FR 42096). The amendment is being made to reflect a change in the Date and Time and Agenda portions of the document. The meeting scheduled for September 11, 2006, has been cancelled. There are no other changes. FOR FURTHER INFORMATION CONTACT: Sohail Mosaddegh, Center for Drug Evaluation and Research (HFD–21), Food and Drug Administration, 5600 Fishers Lane (for express delivery, 5630 Fishers Lane, rm. 1093), Rockville, MD 20857, 301–827–7001, FAX: 301–827– 6776, e-mail: sohail.mosaddegh@fda.hhs.gov, or FDA Advisory Committee Information Line, 1–800–741–8138 (301–443–0572 in the Washington DC area), code 3014512530. Please call the Information Line for upto-date information on this meeting. SUPPLEMENTARY INFORMATION: In the Federal Register of July 25, 2006 (71 FR 42096), FDA announced that a meeting of the Anti-Infective Drugs would be held on September 11 and 12, 2006. On page 42096, in the second column, the Date and Time portion of the meeting is amended to read as follows: Date and Time: The meeting will held on September 12, 2006, from 8 a.m. to 5 p.m. On page 42096, third column, the Agenda portion of the meeting is amended to read as follows: Agenda: On September 12, 2006, the committee will discuss supplemental SUMMARY: VerDate Aug<31>2005 new drug application (sNDA) 21–158/S– 006, FACTIVE (gemifloxacin mesylate) Tablets, submitted by Oscient Pharmaceuticals Corp., for the proposed treatment of acute baterial sinusitis. This notice is issued under the Federal Advisory Committee Act (5 U.S.C. app. 2) and 21 CFR part 14, relating to advisory committees. Jkt 208001 Proposed Data Collection; Comment Request; California Health Interview Survey 2007 SUMMARY: In compliance with the requirement of Section 3506(c)(2)(A) of the Paperwork Reduction Act of 1995 for opportunity for public comment on proposed data collection projects, National Cancer Institute (NCI), the National Institute of Health (NIH) will publish periodic summaries of proposed projects to be submitted to the Office of Management and Budget (OMB) for review and approval. The first California Health Interview Survey (CHIS) Cancer Control Module (CCM) took place in 2001 (2000 CHIS CCM, OMB No. 0925–0478, Federal Register, May 8, 2000, Vol. 65, No. 89, p. 26620). The second survey took place in 2003 (2003 CHIS CCM, OMB No. 0925–0518, Federal Register, October 3, 2002, Volume 67, No. 192, pp. 62067– 62068) and the third in 2005 (2005 CHIS CCM, OMB No. 0925–0000, Federal Register, Vol. 69, No. 150, Aug. 5, 2004, pp. 47450–47451, and Federal Register, Vol. 70, No. 1, Jan. 3, 2005, pp. 93–94). Proposed Collection Title: California Health Interview Survey (CHIS) 2007 Cancer Control Module (CCM). Type of Information Collection Request: New. Need and Use of Information Collection: The NCI has sponsored three Cancer Control Modules in the California Health Interview Survey (CHIS), and will be sponsoring a fourth to be administered in 2007. The CHIS is a telephone survey designed to provide population-based, PO 00000 Frm 00037 Fmt 4703 Sfmt 4703 51833 standardized health-related data to assess California’s progress in meeting Healthy People 2010 objectives for the nation and the state. The CHIS sample is designed to provide statistically reliable estimates statewide, for California counties, and for California’s ethnically and racially diverse population. Initiated by the UCLA Center for Health Policy Research, the California Department of Health Services, and the California Public Health Institute, the survey is funded by a number of public and private sources. It was first administered in 2001 to 55,428 adults and subsequently in 2003 and 2005 to 42,043 and 43,020 adults respectively. These adults are a representative sample of California’s non-institutionalized population living in households. CHIS 2007, the fourth bi-annual survey, is planned for administration to 55,000 adult Californians. The cancer control module, which is similar to that administered in CHIS 2001, CHIS 2003, and CHIS 2005, will allow NCI to examine trends in breast cancer screening and diagnosis, as well as to study other cancer-related topics such as diet, physical activity, and obesity. Because California is the most populous and the most racially and ethnically diverse state in the nation, the CHIS 2007 sample will yield adequate numbers of respondents in key ethnic and racial groups, including African Americans, Latinos, Asians, and American Indian/Alaska Natives. The Latino group will include large numbers of respondents in the Mexican, Central American, South American, and other Latino subgroups; the Asian group will include large numbers of respondents in the Chinese, Filipino, Japanese, Vietnamese, and Korean subgroups. NCI will compare the CHIS and National Health Interview Survey (NHIS) data in order to conduct comparative analyses and better estimate cancer risk factors and screening among racial/ethnic minority populations. The CHIS sample size also permits NCI to create estimates for ethnic subdomains of the population, for which NHIS has insufficient numbers for analysis. Frequency of Response: One-time. Affected public: Individuals or households. Types of Respondents: U.S. adults (persons 18 years of age and older). The annual reporting burden is as follows. E:\FR\FM\31AUN1.SGM 31AUN1 51834 Federal Register / Vol. 71, No. 169 / Thursday, August 31, 2006 / Notices TABLE A.—ANNUALIZED BURDEN ESTIMATES FOR CHIS 2007 DATA COLLECTION Estimated number of respondents Data collection Frequency of response Average time per response Annual hour burden (1) Pilot Test Adult Demographics ................................................................. CCM ............................................................................................................... (2) Full Survey Adult Demographics .............................................................. CCM ............................................................................................................... 150 150 55,000 55,000 1 1 1 1 .07 .03 .07 .03 11 5 3,850 1,650 Totals ...................................................................................................... 55,150 1 .1 5,516 There are no Capital Costs to report. There are no Operating or Maintenance Costs to report. Request for Comments: Written comments and/or suggestions from the public and affected agencies are invited on one or more of the following points: (1) Whether the proposed collection of information is necessary for the proposed performance of the functions of the agency, including whether the information shall have practical utility; (2) The accuracy of the agency’s estimate of the burden of the proposed collection of information including the validity of the methodology and assumptions used; (3) Ways to enhance the quality, utility, and clarity of the information to be collected; and (4) Ways to minimize the burden of the collection of information on those who are to respond, including the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology. To request more information on the proposed project or to obtain a copy of the data collection plans and instruments, contact Nancy Breen, Ph.D., Project Officer, National Cancer Institute, EPN 4005, 6130 Executive Boulevard MSC 7344, Bethesda, Maryland 20852–7344, or call non-toll free number 301–496–8500 or FAX your request, including your address to breenn@mail.nih.gov. Comments Due Date: Comments regarding this information collection are best assured of having their full effect if received within 60 days of this publication. FOR FURTHER INFORMATION CONTACT: erjones on PROD1PC72 with NOTICES Dated: August 24, 2006. Rachelle Ragland-Greene, NCI Project Clearance Liaison, National Institutes of Health. [FR Doc. 06–7328 Filed 8–30–06; 8:45 am] BILLING CODE 4140–01–P VerDate Aug<31>2005 15:29 Aug 30, 2006 Jkt 208001 DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Government-Owned Inventions; Availability for Licensing National Institutes of Health, Public Health Service, HHS. ACTION: Notice. AGENCY: SUMMARY: The inventions listed below are owned by an agency of the U.S. Government and are available for licensing in the U.S. in accordance with 35 U.S.C. 207 to achieve expeditious commercialization of results of federally funded research and development. Foreign patent applications are filed on selected inventions to extend market coverage for companies and may also be available for licensing. ADDRESSES: Licensing information and copies of the U.S. patent applications listed below may be obtained by writing to the indicated licensing contact at the Office of Technology Transfer, National Institutes of Health, 6011 Executive Boulevard, Suite 325, Rockville, Maryland 20852–3804; telephone: 301/ 496–7057; fax: 301/402–0220. A signed Confidential Disclosure Agreement will be required to receive copies of the patent applications. Novel Acylthiol Compositions and Methods of Making and Using Them Description of Technology: This invention provides a novel family of acylthiols and uses thereof. More specifically, this invention provides effective inhibitors of HIV that selectively target its highly conserved nucleocapsid protein (NCp7) by interacting with metal chelating structures of a zinc finger-containing protein. Because of the mutationally intolerant nature of NCp7, drug resistance is much less likely to occur with compounds attacking this target. In addition, these drugs should inactivate all types and strains of HIV and could also inactivate other retroviruses, since most retroviruses share one or two PO 00000 Frm 00038 Fmt 4703 Sfmt 4703 highly conserved zinc fingers that have the CCHC motif of the HIV Ncp7. Finally, this invention could be very useful for the large-scale practical synthesis of HIV inhibitors, because these compounds can be prepared by using inexpensive starting materials and facile reactions. Thus, it opens the possibility that an effective drug treatment for HIV could be made available to much larger populations. These thioesters may also be used as an active component in topical applications that serve as a barrier to HIV infection. Inventors: John K. Inman (NIAID), Atul Goel (NCI), Ettore Appella (NCI), James A. Turpin (NIAID), Marco Schito (NCI). Publications: 1. ML Schito, A Goel, Y Song, JK Inman, RJ Fattah, WG Rice, JA Turpin, A Sher, E Appella. In vitro antiviral activity of novel human immunodeficiency virus type 1 nucleocapsid p7 zinc finger inhibitors in a transgenic murine model. AIDS Res Hum Retroviruses. 2003 Feb;19(2):91– 101. 2. P Srivastava, M Schito, RJ Fattah, T Hara, T Hartman, RW Buckheit Jr, JA Turpin, JK Inman, E Appella. Optimization of unique, uncharged thioesters as inhibitors of HIV replication. Bioorg Med Chem. 2004 Dec 15;12(24):6437–6450. 3. LM Jenkins, JC Byrd, T Hara, P Srivastava, SJ Mazu, SJ Stahl, JK Inman, E Appella, JG Omichinski, P Legault. Studies on the mechanism of inactivation of the HIV–1 nucleocapsid protein NCp7 with 2mercaptobenzamide thioesters. J Med Chem. 2005 Apr 21;48(8):2847–2858. 4. V Basrur, Y Song, SJ Mazur, Y Higashimoto, JA Turpin, WG Rice, JK Inman, E Appella. Inactivation of HIV– 1 nucleocapsid protein P7 by pyridinioalkanoyl thioesters. Characterization of reaction products and proposed mechanism of action. J Biol Chem. 2000 May 19;275(20):14890– 14897. 5. JA Turpin, Y Song, JK Inman, M Huang, A Wallqvist, A Maynard, DG E:\FR\FM\31AUN1.SGM 31AUN1

Agencies

[Federal Register Volume 71, Number 169 (Thursday, August 31, 2006)]
[Notices]
[Pages 51833-51834]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 06-7328]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Proposed Data Collection; Comment Request; California Health 
Interview Survey 2007

SUMMARY: In compliance with the requirement of Section 3506(c)(2)(A) of 
the Paperwork Reduction Act of 1995 for opportunity for public comment 
on proposed data collection projects, National Cancer Institute (NCI), 
the National Institute of Health (NIH) will publish periodic summaries 
of proposed projects to be submitted to the Office of Management and 
Budget (OMB) for review and approval.
    The first California Health Interview Survey (CHIS) Cancer Control 
Module (CCM) took place in 2001 (2000 CHIS CCM, OMB No. 0925-0478, 
Federal Register, May 8, 2000, Vol. 65, No. 89, p. 26620). The second 
survey took place in 2003 (2003 CHIS CCM, OMB No. 0925-0518, Federal 
Register, October 3, 2002, Volume 67, No. 192, pp. 62067-62068) and the 
third in 2005 (2005 CHIS CCM, OMB No. 0925-0000, Federal Register, Vol. 
69, No. 150, Aug. 5, 2004, pp. 47450-47451, and Federal Register, Vol. 
70, No. 1, Jan. 3, 2005, pp. 93-94).

Proposed Collection

    Title: California Health Interview Survey (CHIS) 2007 Cancer 
Control Module (CCM). Type of Information Collection Request: New. Need 
and Use of Information Collection: The NCI has sponsored three Cancer 
Control Modules in the California Health Interview Survey (CHIS), and 
will be sponsoring a fourth to be administered in 2007.
    The CHIS is a telephone survey designed to provide population-
based, standardized health-related data to assess California's progress 
in meeting Healthy People 2010 objectives for the nation and the state. 
The CHIS sample is designed to provide statistically reliable estimates 
statewide, for California counties, and for California's ethnically and 
racially diverse population. Initiated by the UCLA Center for Health 
Policy Research, the California Department of Health Services, and the 
California Public Health Institute, the survey is funded by a number of 
public and private sources. It was first administered in 2001 to 55,428 
adults and subsequently in 2003 and 2005 to 42,043 and 43,020 adults 
respectively. These adults are a representative sample of California's 
non-institutionalized population living in households.
    CHIS 2007, the fourth bi-annual survey, is planned for 
administration to 55,000 adult Californians. The cancer control module, 
which is similar to that administered in CHIS 2001, CHIS 2003, and CHIS 
2005, will allow NCI to examine trends in breast cancer screening and 
diagnosis, as well as to study other cancer-related topics such as 
diet, physical activity, and obesity.
    Because California is the most populous and the most racially and 
ethnically diverse state in the nation, the CHIS 2007 sample will yield 
adequate numbers of respondents in key ethnic and racial groups, 
including African Americans, Latinos, Asians, and American Indian/
Alaska Natives. The Latino group will include large numbers of 
respondents in the Mexican, Central American, South American, and other 
Latino subgroups; the Asian group will include large numbers of 
respondents in the Chinese, Filipino, Japanese, Vietnamese, and Korean 
subgroups. NCI will compare the CHIS and National Health Interview 
Survey (NHIS) data in order to conduct comparative analyses and better 
estimate cancer risk factors and screening among racial/ethnic minority 
populations. The CHIS sample size also permits NCI to create estimates 
for ethnic subdomains of the population, for which NHIS has 
insufficient numbers for analysis.
    Frequency of Response: One-time. Affected public: Individuals or 
households. Types of Respondents: U.S. adults (persons 18 years of age 
and older).
    The annual reporting burden is as follows.

[[Page 51834]]



                       Table A.--Annualized Burden Estimates for CHIS 2007 Data Collection
----------------------------------------------------------------------------------------------------------------
                                                     Estimated
                 Data collection                     number of     Frequency of    Average time     Annual hour
                                                    respondents      response      per response       burden
----------------------------------------------------------------------------------------------------------------
(1) Pilot Test Adult Demographics...............             150               1             .07              11
CCM.............................................             150               1             .03               5
(2) Full Survey Adult Demographics..............          55,000               1             .07           3,850
CCM.............................................          55,000               1             .03           1,650
                                                 ---------------------------------------------------------------
    Totals......................................          55,150               1             .1            5,516
----------------------------------------------------------------------------------------------------------------
There are no Capital Costs to report. There are no Operating or Maintenance Costs to report.

    Request for Comments: Written comments and/or suggestions from the 
public and affected agencies are invited on one or more of the 
following points: (1) Whether the proposed collection of information is 
necessary for the proposed performance of the functions of the agency, 
including whether the information shall have practical utility; (2) The 
accuracy of the agency's estimate of the burden of the proposed 
collection of information including the validity of the methodology and 
assumptions used; (3) Ways to enhance the quality, utility, and clarity 
of the information to be collected; and (4) Ways to minimize the burden 
of the collection of information on those who are to respond, including 
the use of appropriate automated, electronic, mechanical, or other 
technological collection techniques or other forms of information 
technology.

FOR FURTHER INFORMATION CONTACT: To request more information on the 
proposed project or to obtain a copy of the data collection plans and 
instruments, contact Nancy Breen, Ph.D., Project Officer, National 
Cancer Institute, EPN 4005, 6130 Executive Boulevard MSC 7344, 
Bethesda, Maryland 20852-7344, or call non-toll free number 301-496-
8500 or FAX your request, including your address to 
breenn@mail.nih.gov.
    Comments Due Date: Comments regarding this information collection 
are best assured of having their full effect if received within 60 days 
of this publication.

    Dated: August 24, 2006.
Rachelle Ragland-Greene,
NCI Project Clearance Liaison, National Institutes of Health.
[FR Doc. 06-7328 Filed 8-30-06; 8:45 am]
BILLING CODE 4140-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.